Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Other Announcement

Alivus Life Sciences Other Announcement

Alivus Life Sciences Limited filed its Annual Secretarial Compliance Report for FY2025-26. The report confirms full regulatory compliance with no adverse observations from the practicing company secretary.

Source

BSE filing, NSE: ALIVUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alivus Life Sciences Ltd: key numbers

Share price
₹1,395.00
Market cap
₹17,127 Cr
Revenue (annual)
₹2,552 Cr
Net profit (annual)
₹564.5 Cr
P/E (TTM)
28.4×Sector 46.1×
Promoter holding
74.85%-0.02% QoQ
FII holding
5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alivus Life Sciences Ltd

All →
19:21 IST BSE
Financial Results

Alivus Life Sciences Q2 FY27 Results: Net Profit ₹196.7 Cr, Up 51.3% YoY

Alivus Life Sciences Ltd reported revenue from operations of ₹682 Cr (+16.0% YoY) and net profit of ₹196.7 Cr (+51.3% YoY) for Q2 FY27.

Key figure
Net profit ₹196.7 Cr · +51.3% YoY

Other other announcement announcements

All →